Clinic business

Irwin Naturals agrees to add Idaho clinic to its nationwide chain of psychedelic mental health clinics

LOS ANGELES, October 04, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) reached a binding agreement on September 30, 2022 to acquire Ketamine Infusions of Idaho, PLLCwho operates a clinic in Idaho Falls.

The clinic will join Irwin Naturals Emergence, a rapidly growing national chain of psychedelic mental health clinics, which has already reached agreements to add a total of 11 clinics in six different states. This clinic will be the first in the chain in Idaho.

Klee IrwinCEO of Irwin Naturals said: “We are so impressed with the care and expertise that Christina Stubbs and his team provide, and we are truly excited to welcome this clinic to our growing family. Additions like this are how we will achieve our goal of placing Irwin Naturals Emergence at the forefront of psychedelic mental health care in this country.

Ketamine Infusions Idaho was founded in 2020 by Christina Stubbswho grew up in Southeast Idaho. She earned her Bachelor of Science in Nursing at University of Utahand his work at University Neuropsychiatric Institute in Salt Lake City makes her a mental health enthusiast. In 2011, she earned her Masters in Nursing Anesthesia from the University of New England.

Christina StubbsCRNA, owner of Ketamine Infusions of Idaho, said, “We built our practice on the unshakeable belief that we could help those who were suffering. Being part of Irwin Naturals Emergence not only validates this belief, but it allows us to be part of a network that will make these treatments available nationwide behind a trusted brand.

Irwin Naturals dates back to 1994 when it began providing best in class nutraceuticals. Today, Irwin Naturals products are stocked on the shelves of more than 100,000 display cases in North America and its brand is recognized in 80% of WE houses.1

Earlier this year, the company announced plans to create a nationwide chain of psychedelic mental health clinics under the umbrella of Irwin Naturals Emergence, a wholly owned subsidiary of the company. The company has begun monitoring the more than 600 independent ketamine clinics currently operating in United States, seeking to identify clinics that were profitable and exhibited a level of patient care consistent with the Irwin Naturals brand. When it identified clinics that met both criteria, the Company sought to add them to the chain.

Irwin Naturals Emergence has already entered into agreements that will add or have added 11 clinics in six different states: Ohio, Vermont, Iowa, New Hampshiretwo in Georgia and five in Florida.

Building a national chain will provide efficiencies and savings that come from economies of scale. The incorporation of Irwin Naturals best practices will also help reduce operating costs, a saving that can be passed on to customers by offering scaling discounts and even pro bono treatment for those who need it.

But the greatest value can come from the trust of customers that Irwin Naturals has been built over the past 28 years. He will be an ambassador for this new approach to mental health.

Klee Irwin, Irwin Naturals CEO, “We provide a level of comfort just by being in this space. We have safely cared for your health needs for 28 years, and will continue to do so with these new, life-changing treatments because they are safe, effective and can provide relief to those in need.

Currently, ketamine is the only psychedelic available for use in United States outside of clinical trials. However, MDMA and psilocybin may be licensed for therapeutic use in the future. The effectiveness of these treatments in clinical trials indicates the potential to further revolutionize the field of mental health treatment.

Terms of trade

The transaction is charged up front, aligning the sellers’ interest with the Company and its shareholders. Full consideration is to be paid in cash and shares, with the maximum payable subject to a number of milestones related to profitability and operational objectives. Further details will be provided at closing.

About Irwin Naturals

Irwin Naturals has been a household name and top herbal supplement formulator since 1994. It is now leveraging its brand to enter both the cannabis and psychedelic industries. On a mission to heal the world with plant medicine, Irwin has operated profitably for over 27 years2. Irwin’s growing product portfolio is available at more than 100,000 retail locations across North Americawhere nearly 100 million people know the Irwin Naturals Mark.3 In 2018, the company first leveraged its brand to expand into the cannabis industry by launching hemp-based CBD products to the mass market. The company is now leveraging its famous halo of brand trust in a bid to become one of the first known brands to offer THC products and psychedelic treatments for mental health. Irwin Naturals became a listed company on the Canadian Securities Exchange (CSE) in August 2021. The Company’s shares began trading on the OTCQB Venture Market in November 2021. More information on the Company’s shares can be found via Bloomberg as well as the the wall street journal.

For investor information on the Company, please visit

To contact the Company’s Investor Relations Department, please call toll-free (800) 883-4851 or email

Klee Irwin
________________________________Klee IrwinChief executive officer
Such. : 310-306-3636

IR information

press contact

Irwin Naturals Investor RelationsCassandra Bassanetti – DrummSuch. : 310-306-3636

Forward-looking information

This press release contains certain forward-looking statements that reflect the Company’s management’s current beliefs and/or expectations regarding future performance, business and events. Forward-looking statements can often be identified by words such as “may”, “will”, “should”, “could”, “should”, “believe”, “estimate”, “project”, “potential”, “s ‘expects’, ‘plans’, ‘intends’, ‘anticipates’, ‘targets’, ‘continues’, ‘plans’, ‘designs’, ‘aims’, ‘objectives’, or the negative of these similar or comparable words or other words Forward-looking statements are based on then-current expectations, beliefs, assumptions, estimates and forecasts about the business, industry and markets in which the Company operates. The forward-looking statements contained in this press release include statements relating to information regarding the Company’s ability to execute the terms of the transaction referenced herein; the receipt of all necessary approvals, including regulatory approvals; expectations regarding future other economic, market and commercial factors and competitive; and the Company entering and doing business in the WE cannabis and psychedelic markets. The Company’s entry into these new business areas is in its preliminary stages and may be subject to the approval of the Company’s Board of Directors as well as any regulatory approval, including that of the Stock Exchange. Canadian values. These statements are based on numerous assumptions that management believes are reasonable under the circumstances and are subject to a number of risks and uncertainties, including, without limitation: approval by the Board of Directors and regulatory, including Canadian Stock Exchange approval; Irwin being able to acquire and/or establish business relationships to penetrate these new markets; the Company obtaining the required licenses; and changes in regulations and laws regarding cannabis or psychedelics. Further information on the regulatory environment and risks will be contained in future publications. Forward-looking statements are subject to a number of known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements to differ materially from those expressed or implied by such statements. prospective. Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Accordingly, readers should not place undue reliance on forward-looking statements and information, which are qualified in their entirety by this cautionary statement. The Company undertakes no obligation to publicly release revisions to update voluntary forward-looking statements, except as required by applicable securities law.

Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

THE SOURCE: Irwin Naturals Inc.


1 Based on a formal company survey with a randomly selected sample of 500 adults.
2 Under several corporate structures, Klee Irwin has operated the Irwin brand profitably since 1994, as measured by EBITDA adjusted for extraordinary costs.
3 Consumer brand recognition information is based on a formal company survey of a randomly selected sample of 500 adults.

main logo

Source: Irwin Naturals

2022 GlobeNewswire, Inc., source Press Releases